Author Question: Someone who is an erotophobic _______. a. responds with positive reactions to sexual topics b. ... (Read 215 times)

frankwu

  • Hero Member
  • *****
  • Posts: 549
Someone who is an erotophobic _______.
 
  a. responds with positive reactions to sexual topics
  b. is less comfortable with sexual issues
  c. has a sexually transmitted infection
  d. uses masturbation as their main sexual activity

Question 2

Mark scored pretty low on the Sexual Inhibition Scale (SIS) and pretty high on the Sexual Excitation Scale (SES). How does he compare to other males?
 
  a. His SIS and SES scores are similar to the average scores for men.
  b. His SIS score is higher than the average scores for men.
  c. His SIS score is lower than the average scores for men.
  d. His SES score is higher than the average scores for men.



fur

  • Sr. Member
  • ****
  • Posts: 309
Answer to Question 1

Answer: B

Answer to Question 2

Answer: A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library